• Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Receives Average Recommendation of "Buy" from Analysts

    Source: Buzz FX / 02 Jan 2025 08:56:14   America/Chicago


    Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Receives Average Recommendation of "Buy" from Analysts Written by MarketBeat January 2, 2025 Share Link copied to clipboard. Shares of Corvus Pharmaceuticals, Inc.
    Read more...
Share on,